Structure of Candesantan Cilexetil CAS 145040-37-5

Candesantan Cilexetil CAS 145040-37-5

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

145040-37-5

Name

Candesantan Cilexetil

Synonyms

1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate [ACD/IUPAC Name]
1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl-2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazol-7-carboxylat [German] [ACD/IUPAC Name]
1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl-2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazol-7-carboxylat [German]
145040-37-5 [RN]
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester [ACD/Index Name]
2-Ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester
2-Éthoxy-1-{[2′-(1H-tétrazol-5-yl)-4-biphénylyl]méthyl}-1H-benzimidazole-7-carboxylate de 1-{[(cyclohexyloxy)carbonyl]oxy}éthyle [French] [ACD/IUPAC Name]
2-éthoxy-1-{[2′-(1H-tétrazol-5-yl)biphényl-4-yl]méthyl}-1H-benzimidazole-7-carboxylate de 1-{[(cyclohexyloxy)carbonyl]oxy}éthyle [French]
Candesartan cilexetil [JAN] [USAN]
R85M2X0D68
UNII:R85M2X0D68
(±)-1-Hydroxyethyl 2-Ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate Cyclohexyl Carbonate (Ester)
(2-ethoxy-1-{[4-(2-(1H-1,2,3,4-tetraazol-5-yl)phenyl)phenyl]methyl}benzimidazol-7-ylcarbonyloxy)ethyl cyclohexyloxyformate
[145040-37-5]
1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-ethox
1-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2-(2h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate
1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2′-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-(cyclohexyloxycarbonyloxy)ethyl 1-((2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1H-Benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2′-(1H-tetrazol-5-yl)(1,1′-biphenyl)-4-yl)-, hydroxide, inner salt, (±)-
2-?ETHOXY-?1-?[[2′-?(2H-?TETRAZOL-?5-?YL)[1,?1′-?BIPHENYL]-?4-?YL]METHYL]-?1-?[[(CYCLOHEXYLOXY)CARBONYL]OXY]ETHYL ESTER-?1H-?BENZIMIDAZOLE-?7-?CARBOXYLIC ACID
2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester-1H-Benzimidazole-7-carboxylic acid
2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
2-Ethoxy-1-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylic acid [ACD/IUPAC Name]
2-Ethoxy-3-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
2-Ethoxy-3-[2′-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
7689-03-4 [RN]
Amias [Trade name]
Atacand [Trade name]
Blopress [Trade name]
BR-75900
C077793
Camptothecine
Candesartan 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
Candesartan celexetil
candesartan cilexetil(?????????)
CANDESARTAN CILEXITIL
DD6672500
H212/91
Kenzen
MFCD00871371 [MDL number]
Parapres
Pharmakon1600-01504261
Racanda
Ratacand [Trade name]
TCV 116 |
TCV116
TCV-116;TCV116;TCV 116;Atacand
TCY 116
TL8000995

Molecular Structure

Structure of Candesantan Cilexetil CAS 145040-37-5

Structure of Candesantan Cilexetil CAS 145040-37-5

SMILES

CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5[nH]nnn5)C(=O)OC(C)OC(=O)OC6CCCCC6

StdInChI

InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)

StdInChIKey

GHOSNRCGJFBJIB-UHFFFAOYSA-N

Molecular Formula

C33H34N6O6

Molecular Weight

610.66

MDL Number

MFCD00871371

Safety Data

Symbol

exclamation-mark-jpgexclamation-mark-jpgGHS08, GHS09

Signal Word

Warning

Hazard Statements

H361-H400

Precautionary Statements

P280

RIDADR

UN 3077 9 / PGIII

WGK Germany

3

Specifications and Other Information of Our Candesantan Cilexetil CAS 145040-37-5

Standard

EP, USP

GMP

CFDA

Basic Patent Situation

US expiry date20120604
EU expiry date20110419 (20120428)
JP expiry date20160428

Package

According to customer requirements to packaging

Storage

Under the room temperature and away from light

Application

Used as Angiotensin II Receptor Antagonist

Links

This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/candesantan-cilexetil-cas-145040-37-5/

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://watson-int.com/candesantan-cilexetil-cas-145040-37-5/